- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Agilent plans to remap healthcare division
Officials at Agilent Technologies, the now independent Massachusetts-based company spun off by computer giant Hewlett Packard, say they are disappointed by the company's latest performance in the healthcare arena.Agilent Technologies is made up of
Officials at Agilent Technologies, the now independent Massachusetts-based company spun off by computer giant Hewlett Packard, say they are disappointed by the company's latest performance in the healthcare arena.
Agilent Technologies is made up of electronics, communications, and healthcare businesses. The company's healthcare products include the Sonos 5500 cardiac ultrasound system, Sonos 4500 digital imaging system, and the ImagePoint multispecialty digital ultrasound system.
In the second quarter of 2000 (end-April 30), the electronics and communications businesses did well, but healthcare did not, said Ned Barnholt, Agilent's president and CEO.
Recently published reports speculating that Agilent will sell off its healthcare business if performance continues to decline are not true, said Heidi Wilson, Agilent spokesperson. Instead, Agilent has plans to restructure the division, she said.
Agilent reported that second quarter 2000 net revenue rose to $2.5 billion, up 24% over second quarter 1999. Net earnings for the quarter rose 6% to $166 million, compared with $157 million in the same quarter last year.
Orders in healthcare during second quarter 2000 were $349 million, down 9% compared with second quarter 1999. There are two factors that slowed the healthcare business, according to the firm: hospital purchases that were recorded in fiscal 1999 to avoid possible Y2K issues and increasing government pressure on hospitals from the balanced budget amendment to keep costs down.
Wilson said the healthcare division's restructuring plans include accelerating product promotions and slowing down noncritical hiring. The results of the changes will be evaluated by top company officials, she said.
"If, in a certain amount of time, a segment of business is not living up to expected results, of course the company will look at its options," Wilson said.
Wilson said there will be an announcement of new product availability at the June 11-14 American Society of Echocardiography meeting in Chicago. In addition, Agilent has signed an agreement to acquire Zymed, an Oxnard, CA-based provider of cardiac analysis solutions.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
